Abstract
Due to systolic blood pressure (SBP) amplification, brachial SBP may not accurately reflect central SBP, the pressure the organs are exposed to. Patients with type 2 diabetes (T2D) have vascular irregularities that may affect blood pressure (BP) amplification and central BP indices (i.e. augmentation index [AIx] and augmentation pressure [AP]). By systematic review and meta-analysis, this study aimed firstly to determine the magnitude of central-to-brachial SBP and pulse pressure (PP) amplification in T2D compared to healthy controls and secondly, the difference in AIx and AP between the groups. Online databases were searched for published studies reporting invasive or non-invasive central and brachial SBP in T2D and healthy controls up to the 20th of February 2018. Random effects meta-analyses and meta-regression were used to analyze the studies. Eighteen studies (all non-invasive: 17 radial tonometry, 1 carotid tonometry, 2 brachial oscillometry) with a total of 2758 patients with T2D and 10,561 healthy controls were identified. There was no significant difference in SBP amplification between groups (T2D = 9.9 ± 4.7, healthy controls = 9.6 ± 4.5 mmHg, p = 0.84; pooled difference = 0.64 mmHg, 95%CI −0.27 1.54, p = 0.17) or PP amplification ratio (p = 0.16). However, among these studies, central BP indices (AIx corrected for heart rate and AP) were significantly higher in T2D (p < 0.05 for both). Despite a similar magnitude of central-to-brachial SBP amplification, patients with T2D have increased central systolic loading (AIx and AP) that cannot be discerned from brachial BP alone.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Psaty BM, Furberg CD, Kuller LH, Cushman M, Savage PJ, Levine D, et al. Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: the cardiovascular health study. Arch Intern Med. 2001;161:1183–92.
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.
Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005;45:142–61.
Safar ME, Blacher J, Pannier B, Guerin AP, Marchais SJ, Guyonvarc’h PM, et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension. 2002;39:735–8.
Agabiti-Rosei E, Mancia G, O’Rourke MF, Roman MJ, Safar ME, Smulyan H, et al. Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension. 2007;50:154–60.
Picone DS, Schultz MG, Otahal P, Aakhus S, Al-Jumaily AM, Black JA, et al. Accuracy of cuff-measured blood pressure: systematic reviews and meta-analyses. J Am Coll Cardiol. 2017;70:572–86.
Millasseau S, Agnoletti D. Non-invasive estimation of aortic blood pressures: a close look at current devices and methods. Curr Pharm Des. 2015;21:709–18.
Kollias A, Lagou S, Zeniodi ME, Boubouchairopoulou N, Stergiou GS. Association of central versus brachial blood pressure with target-organ DamageNovelty and significance. Hypertension. 2016;67:183–90.
McVeigh G, Brennan G, Johnston G, McDermott B, McGrath L, Henry W, et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1992;35:771–6.
Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation. 2002;106:2085–90.
Agnoletti D, Lieber A, Zhang Y, Protogerou AD, Borghi C, Blacher J, et al. Central hemodynamic modifications in diabetes mellitus. Atherosclerosis. 2013;230:315–21.
Schram MT, Henry RM, van Dijk RA, Kostense PJ, Dekker JM, Nijpels G, et al. Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes The Hoorn Study. Hypertension. 2004;43:176–81.
Megnien JL, Simon A, Valensi P, Flaud P, Merli I, Levenson J. Comparative effects of diabetes mellitus and hypertension on physical properties of human large arteries. J Am Coll Cardiol. 1992;20:1562–8.
Wilkinson IB, Prasad K, Hall IR, Thomas A, MacCallum H, Webb DJ, et al. Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia. J Am Coll Cardiol. 2002;39:1005–11.
Mahmud A, Feely J. Effect of smoking on arterial stiffness and pulse pressure amplification. Hypertension. 2003;41:183–7.
Carlsen RK, Peters CD, Khatir DS, Laugesen E, Bøtker HE, Winther S, et al. Estimated aortic blood pressure based on radial artery tonometry underestimates directly measured aortic blood pressure in patients with advancing chronic kidney disease staging and increasing arterial stiffness. Kidney Int. 2016;90:869–77.
Boutouyrie P, London GM, Sharman JE. Estimating central blood pressure in the extreme vascular phenotype of advanced kidney disease. Kidney Int. 2016;90:736–9.
Sharman J, Stowasser M, Fassett R, Marwick T, Franklin S. Central blood pressure measurement may improve risk stratification. J Hum Hypertens. 2008;22:838–44.
Li Y, Gu H, Fok H, Alastruey J, Chowienczyk P. Forward and backward pressure waveform morphology in HypertensionNovelty and significance. Hypertension. 2017;69:375–81.
De Angelis L, Millasseau SC, Smith A, Viberti G, Jones RH, Ritter JM, et al. Sex differences in age-related stiffening of the aorta in subjects with type 2 diabetes. Hypertension. 2004;44:67–71.
Brooks B, Molyneaux L, Yue D. Augmentation of central arterial pressure in Type 2 diabetes. Diabeteic Med. 2001;18:374–80.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA.et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Plos medicine, 2009;10:46–49.
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283:2008–12.
Wells G. The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis. 2004. http://www, ohri ca/programs/clinical_epidemiology oxford htm.
Maple-Brown LJ, Piers LS, O’Rourke MF, Celermajer DS, O’Dea K. Central obesity is associated with reduced peripheral wave reflection in Indigenous Australians irrespective of diabetes status. J Hypertens. 2005;23:1403–7.
Maple-Brown LJ, Piers LS, O’Rourke MF, Celermajer DS, O’Dea K. Increased arterial stiffness in remote Indigenous Australians with high risk of cardiovascular disease. J Hypertens. 2007;25:585–91.
Scott JA, Coombes JS, Prins JB, Leano RL, Marwick TH, Sharman JE. Patients with type 2 diabetes have exaggerated brachial and central exercise blood pressure: relation to left ventricular relative wall thickness. Am J Hypertens. 2008;21:715–21.
Tamminen M, Westerbacka J, Vehkavaara S, Yki-Järvinen H. Insulin-induced decreases in aortic wave reflection and central systolic pressure are impaired in type 2 diabetes. Diabetes Care. 2002;25:2314–9.
Afsar B, Elsurer R. The relationship between central hemodynamics, morning blood pressure surge, glycemic control and sodium intake in patients with type 2 diabetes and essential hypertension. Diabetes Res Clin Pract. 2014;104:420–6.
Oehlert GW. A note on the delta method. Am Stat. 1992;46:27–9.
Chirinos JA, Segers P, Gillebert TC, De Buyzere ML, Khan ZA, Khawar U, et al. Central pulse pressure and its hemodynamic determinants in middle-aged adults with impaired fasting glucose and diabetes the asklepios study. Diabetes Care. 2013;36:2359–65.
Ring M, Eriksson MJ, Fritz T, Nyberg G, Östenson CG, Krook A, et al. Influence of physical activity and gender on arterial function in type 2 diabetes, normal and impaired glucose tolerance. Diab Vasc Dis Res. 2015;12:315–24.
Climie RE, Srikanth V, Keith LJ, Davies JE, Sharman JE. Exercise excess pressure and exercise-induced albuminuria in patients with type 2 diabetes mellitus. Am J Physiol-Heart Circ Physiol. 2015;308:H1136–H42.
McEniery CM, Yasmin, McDonnell B, Munnery M, Wallace SM, Rowe CV, et al. Central pressure: variability and impact of cardiovascular risk factors: the Anglo-Cardiff Collaborative Trial II. Hypertension. 2008;51:1476–82.
Recio-Rodriguez JI, Gomez-Marcos MA, Patino-Alonso MC, Agudo-Conde C, Rodriguez-Sanchez E, Garcia-Ortiz L. Abdominal obesity vs general obesity for identifying arterial stiffness, subclinical atherosclerosis and wave reflection in healthy, diabetics and hypertensive. BMC Cardiovasc Disord. 2012;12:3.
Weir MR, Townsend RR, Fink JC, Teal V, Anderson C, Appel L, et al. Hemodynamic correlates of proteinuria in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6:2403–10.
Climie RE, Srikanth V, Beare R, Keith LJ, Fell J, Davies JE, et al. Aortic reservoir characteristics and brain structure in people with type 2 diabetes mellitus; a cross sectional study. Cardiovasc Diabetol. 2014;13:143.
Kolade OO, O’Moore-Sullivan TM, Stowasser M, Coombes JS, Fassett RG, Marwick TH, et al. Arterial stiffness, central blood pressure and body size in health and disease. Int J Obes. 2012;36:93–9.
Sacre JW, Holland DJ, Jenkins C, Sharman JE. Augmentation index immediately after maximal exercise in patients with type 2 diabetes mellitus. Med Sci Sports Exerc. 2012;44:75–83.
Climie R, Nikolic S, Otahal P, Keith L, Sharman J. Augmentation index and arterial stiffness in patients with type 2 diabetes mellitus. Artery Res. 2013;7:194–200.
Schultz M, Climie R, Nikolic S, Ahuja K, Sharman J. Persistent elevation of central pulse pressure during postural stress in patients with type 2 diabetes mellitus. J Hum Hypertens. 2013;27:437.
Kimoto E, Shoji T, Shinohara K, Inaba M, Okuno Y, Miki T, et al. Preferential stiffening of central over peripheral arteries in type 2 diabetes. Diabetes. 2003;52:448–52.
Sharman JE, Fang ZY, Haluska B, Stowasser M, Prins JB, Marwick TH. Left ventricular mass in patients with type 2 diabetes is independently associated with central but not peripheral pulse pressure. Diabetes Care. 2005;28:937–9.
Wilkinson I, MacCallum H, Rooijmans D, Murray G, Cockcroft J, McKnight J, et al. Increased augmentation index and systolic stress in type 1 diabetes mellitus. QJM. 2000;93:441–8.
McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol. 2005;46:1753–60.
Albaladejo P, Copie X, Boutouyrie P, Laloux B, Déclère AD, Smulyan H, et al. Heart rate, arterial stiffness, and wave reflections in paced patients. Hypertension. 2001;38:949–52.
Vergnaud AC, Protogerou AD, Li Y, Czernichow S, Vesin C, Blacher J, et al. Pulse pressure amplification, adiposity and metabolic syndrome in subjects under chronic antihypertensive therapy: the role of heart rate. Atherosclerosis. 2008;199:222–9.
Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113:1213–25.
Protogerou AD, Stergiou GS, Vlachopoulos C, Blacher J, Achimastos A. The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part II: Evidence for specific class-effects of antihypertensive drugs on pressure amplification. Curr Pharm Des. 2009;15:272–89.
Rahman S, Rahman T, Ismail AAS, Rashid ARA. Diabetes‐associated macrovasculopathy: pathophysiology and pathogenesis. Diabetes Obes Metab. 2007;9:767–80.
Brüel A, Oxlund H. Changes in biomechanical properties, composition of collagen and elastin, and advanced glycation endproducts of the rat aorta in relation to age. Atherosclerosis. 1996;127:155–65.
Agnoletti D, Mansour A, Zhang Y, Protogerou A, Ouerdane S, Blacher J, et al. Clinical interaction between diabetes duration and aortic stiffness in type 2 diabetes mellitus. J Hum Hypertens. 2016;31:189–194.
Reddy GK. AGE-related cross-linking of collagen is associated with aortic wall matrix stiffness in the pathogenesis of drug-induced diabetes in rats. Microvasc Res. 2004;68:132–42.
Hashimoto J, Ito S. Aortic stiffness determines diastolic blood flow reversal in the descending thoracic aorta potential implication for retrograde embolic stroke in hypertension. Hypertension. 2013;62:542–9.
Benchimol A, Desser KB, Gartlan JL. Bidirectional blood flow velocity in the cardiac chambers and great vessels studied with the Doppler ultrasonic flowmeter. Am J Med. 1972;52:467–73.
Chen XF, Wang JA, Lin XF, Tang LJ, Yu WF, Chen H, et al. Diabetes mellitus: is it protective against aortic root dilatation? Cardiology. 2009;112:138–43.
Picone DS, Climie RE, Ahuja KD, Keske MA, Sharman JE. Brachial-to-radial SBP amplification: implications of age and estimated central blood pressure from radial tonometry. J Hypertens. 2015;33:1876–83.
Climie RE, Picone DS, Keske MA, Sharman JE. Brachial-to-radial systolic blood pressure amplification in patients with type 2 diabetes mellitus. J Hum Hypertens. 2016;30:404–9.
Hope SA, Tay DB, Meredith IT, Cameron JD. Use of arterial transfer functions for the derivation of central aortic waveform characteristics in subjects with type 2 diabetes and cardiovascular disease. Diabetes Care. 2004;27:746–51.
Sharman JE, Avolio AP, Baulmann J, Benetos A, Blacher J, Blizzard CL, et al. Validation of non-invasive central blood pressure devices: ARTERY Society task force consensus statement on protocol standardization. Eur Heart J. 2017;38;ehw632.
Acknowledgements
MGS is supported by a National Health and Medical Research Council Australian Early Career Fellowship (reference 1104731).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Climie, R.E., Schultz, M.G., Fell, J.W. et al. Central-to-brachial blood pressure amplification in type 2 diabetes: a systematic review and meta-analysis. J Hum Hypertens 33, 94–105 (2019). https://doi.org/10.1038/s41371-018-0124-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41371-018-0124-4
This article is cited by
-
The effect of non-invasively obtained central blood pressure on cardiovascular outcome in diabetic patients in Assiut University Hospitals
The Egyptian Journal of Internal Medicine (2022)
-
Prediction of cardiovascular events by central blood pressure using radial tonometry in type 2 diabetes mellitus patients
Clinical Hypertension (2022)